Category: Uncategorized

Nov 03 2024

Uncategorized

Bristol Myers posts long-term Phase 3 data for schizophrenia drug Cobenfy – Seeking Alpha

by Clinical Editor

No Comments

Bristol Myers posts long-term Phase 3 data for schizophrenia drug Cobenfy  Seeking Alpha

Nov 02 2024

Uncategorized

A promising schizophrenia drug showed mixed results. What does that mean for patients?

by Clinical Editor

No Comments

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday. The...

Nov 02 2024

Uncategorized

The link between schizophrenia and art

by Clinical Editor

No Comments

Art therapy can help individuals express thoughts and feelings without relying solely on words, providing a valuable outlet for understanding symptoms such as hallucinations. Read more.

Nov 01 2024

Uncategorized

Missing Woman Diagnosed With Schizophrenia Found

by Clinical Editor

No Comments

A 44-year-old woman who was diagnosed with schizophrenia and requires medication has been found after being last seen in an unincorporated area west of South Gate, the Los Angeles County...

Nov 01 2024

Uncategorized

Childhood attention issues linked to risk for psychosis, schizophrenia later

by Clinical Editor

No Comments

A new study finds poor attention spans in childhood, plus certain genes, could play a role in raising the risk for psychosis, schizophrenia.

Oct 31 2024

Uncategorized

Schizophrenia: tax receives millions from OnlyFans, and porn is prohibited — Zheleznyak

by Clinical Editor

No Comments

“Our tax service receives millions of revenues from the OnlyFans service… Therefore, when we say that it is prohibited and at the same time ask to pay taxes for it,...

Oct 31 2024

Uncategorized

Zai Lab presents positive outcomes from KarXT Phase III trial for schizophrenia

by Clinical Editor

No Comments

Zai Lab has reported positive outcomes from its Phase III clinical trial of KarXT (xanomeline and trospium chloride) in China to treat schizophrenia. The registrational bridging trial, which assessed …

Oct 30 2024

Uncategorized

Researchers explore social cognition in schizophrenia subtypes

by Clinical Editor

No Comments

A research team has explored the agreement or discrepancy between subjective social cognitive difficulties and actual cognitive impairment. Their study aimed to identify clinical subtypes in patients …

Oct 30 2024

Uncategorized

Study aims to identify clinical subtypes in patients with schizophrenia

by Clinical Editor

No Comments

A research team led by Professor Takahiro Nemoto at Toho University, in collaboration with Associate Professor Naoki Hashimoto and Assistant Professor Ryo Okubo at Hokkaido University, and Dr. Satoru …

Oct 29 2024

Uncategorized

Digital ‘avatars’ emerging as effective treatment for psychosis

by Clinical Editor

No Comments

The distress from voices heard by schizophrenia patients were lessened when treated using digital avatars, new study showed.